SBI Securities’s Precision BioSciences DTIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.69K Sell
470
-8
-2% -$56 ﹤0.01% 2317
2026
Q1
$2.63K Buy
478
+10
+2% +$46 ﹤0.01% 2319
2025
Q4
$1.95K Sell
468
-338
-42% -$1.92K ﹤0.01% 2387
2025
Q3
$4.45K Buy
806
+335
+71% +$1.6K ﹤0.01% 2094
2025
Q2
$1.98K Buy
471
+1
+0.2% +$5 ﹤0.01% 2388
2025
Q1
$2.24K Buy
470
+25
+6% +$127 ﹤0.01% 2238
2024
Q4
$1.7K Buy
+445
New +$3.25K ﹤0.01% 2374

Other funds holding DTIL

SBI Securities's DTIL Position: Q2 2026 in Review

SBI Securities reduced its Precision BioSciences (DTIL) stake by 1.7% in Q2 2026, selling an estimated $56 and leaving 470 shares worth $3.69K. The position accounts for ﹤0.01% of the portfolio, ranked #2317.

SBI Securities first reported a position in DTIL in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.45K in Q3 2025. 14 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • SBI Securities held 470 shares of Precision BioSciences worth $3.69K as of Q2 2026.
  • SBI Securities sold 8 Precision BioSciences shares in Q2 2026, an estimated $56.
  • Precision BioSciences made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2317 holding.
  • SBI Securities first reported a position in Precision BioSciences in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Precision BioSciences position peaked at $4.45K in Q3 2025.
  • 14 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.